Molecular basis of increased serum resistance among pulmonary isolates of non-typeable Haemophilus influenzae.
Non-typeable Haemophilus influenzae (NTHi), a common commensal of the human pharynx, is also an opportunistic pathogen if it becomes established in the lower respiratory tract (LRT). In comparison to colonizing isolates from the upper airway, LRT isolates, especially those associated with exacerbations of chronic obstructive pulmonary disease, have increased resistance to the complement- and antibody-dependent, bactericidal effect of serum. To define the molecular basis of this resistance, mutants constructed in a serum resistant strain using the mariner transposon were screened for loss of survival in normal human serum. The loci required for serum resistance contribute to the structure of the exposed surface of the bacterial outer membrane. These included loci involved in biosynthesis of the oligosaccharide component of lipooligosaccharide (LOS), and vacJ, which functions with an ABC transporter encoded by yrb genes in retrograde trafficking of phospholipids from the outer to inner leaflet of the cell envelope. Mutations in vacJ and yrb genes reduced the stability of the outer membrane and were associated with increased cell surface hyrophobicity and phospholipid content. Loss of serum resistance in vacJ and yrb mutants correlated with increased binding of natural immunoglobulin M in serum as well as anti-oligosaccharide mAbs. Expression of vacJ and the yrb genes was positively correlated with serum resistance among clinical isolates. Our findings suggest that NTHi adapts to inflammation encountered during infection of the LRT by modulation of its outer leaflet through increased expression of vacJ and yrb genes to minimize recognition by bactericidal anti-oligosaccharide antibodies.
Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Shigeki
S
Nakamura
Mikhail
M
Shchepetov
Ankur B
AB
Dalia
Sarah E
SE
Clark
Timothy F
TF
Murphy
Sanjay
S
Sethi
Janet R
JR
Gilsdorf
Arnold L
AL
Smith
Jeffery N
JN
Weiser
D001770:Blood Bactericidal Activity / Q000235:genetics* / Q000276:immunology; D005798:Genes, Bacterial; D014644:Genetic Variation; D006192:Haemophilus Infections / Q000235:genetics* / Q000276:immunology / Q000382:microbiology; D006193:Haemophilus influenzae / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity; D054884:Host-Pathogen Interactions / Q000235:genetics* / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate / Q000235:genetics / Q000276:immunology; D008168:Lung / Q000276:immunology / Q000382:microbiology; D012141:Respiratory Tract Infections / Q000235:genetics* / Q000276:immunology / Q000382:microbiology
Mol Microbiol. 1994 Jan;11(1):31-41
8145644
Can J Biochem Physiol. 1959 Aug;37(8):911-7
13671378
J Clin Microbiol. 2007 Oct;45(10):3207-17
17687018
Infect Immun. 1997 Mar;65(3):943-50
9038301
Mol Microbiol. 1996 Dec;22(5):951-65
8971716
Clin Infect Dis. 2008 May 15;46(10):1547-54
18419489
Acta Otolaryngol Suppl. 1996;523:128-9
9082757
Pediatr Infect Dis J. 2004 Jan;23(1):41-6
14743045
N Engl J Med. 2002 Aug 15;347(7):465-71
12181400
J Exp Med. 1998 Dec 21;188(12):2381-6
9858525
Biochem Biophys Res Commun. 1982 Oct 29;108(4):1502-7
7181904
Emerg Infect Dis. 2000 Nov-Dec;6(6):622-30
11076721
Anal Bioanal Chem. 2008 Apr;390(7):1861-71
18278588
J Biol Chem. 2004 Oct 22;279(43):44966-75
15319435
Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
11316667
Mol Microbiol. 1998 Nov;30(4):767-75
10094625
Cell. 1989 Nov 17;59(4):657-65
2479481
Mol Microbiol. 2000 Nov;38(4):867-78
11115120
EMBO J. 1996 Oct 1;15(19):5470-9
8895590
Int J Med Microbiol. 2007 Sep;297(5):297-306
17452015
J Bacteriol. 1993 Aug;175(16):5273-5
8349567
Mol Microbiol. 2002 Sep;45(5):1389-406
12207705
J Immunol. 1986 Apr 15;136(8):2994-8
2937839
Am J Respir Crit Care Med. 2001 Dec 1;164(11):2114-9
11739144
Biochemistry. 1992 May 12;31(18):4515-26
1581306
Biochemistry. 1976 Jun 15;15(12):2561-70
820368
J Immunol. 2007 Jan 15;178(2):1002-12
17202363
Infect Immun. 2001 Feb;69(2):695-705
11159957
J Endotoxin Res. 2003;9(3):131-44
12831454
Proc Natl Acad Sci U S A. 2009 May 12;106(19):8009-14
19383799
Infect Immun. 2000 May;68(5):2804-7
10768976
J Immunol. 1997 Jul 15;159(2):970-5
9218618
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8927-32
9671781
Infect Immun. 2007 Jan;75(1):325-33
17088344
Microbiol Mol Biol Rev. 2003 Dec;67(4):593-656
14665678
J Med Microbiol. 1984 Aug;18(1):1-16
6146721
J Clin Microbiol. 2008 Feb;46(2):406-16
18039799
Microbiol Rev. 1985 Mar;49(1):1-32
2580220
J Bacteriol. 1970 Feb;101(2):517-24
5308771
Science. 1995 Jul 28;269(5223):496-512
7542800
Infect Immun. 2006 Nov;74(11):6226-35
16966407
Infect Immun. 1991 Apr;59(4):1278-84
1706317
Mol Microbiol. 2002 Mar;43(6):1471-91
11952899
Science. 1999 Dec 10;286(5447):2156-9
10591647
Infect Immun. 1987 Mar;55(3):513-20
2434425
Lancet. 1997 May 24;349(9064):1498-504
9167458
Infect Immun. 2009 Aug;77(8):3458-65
19451240
Curr Opin Infect Dis. 2003 Apr;16(2):129-34
12734445
BMC Microbiol. 2008 May 29;8:83
18510729